RZLT

RZLT

USD

Rezolute Inc. Common Stock (NV)

$8.900-0.020 (-0.224%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$8.920

Haut

$9.000

Bas

$8.820

Volume

1.64M

Fondamentaux de l'Entreprise

Capitalisation Boursière

808.4M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

1.24M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $2.215Actuel $8.900Haut $10.04

Actualités Connexes

Analyst Upgrades

Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $17

Citizens analyst Jason N. Butler maintains Rezolute with a Market Outperform and raises the price target from $9 to $17.

Voir plus
Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $17
GlobeNewswire

Rezolute to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ:RZLT) ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today

Voir plus
Rezolute to Participate in Upcoming Investor Conferences
GlobeNewswire

Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), ("Rezolute" or the "Company"), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today

Voir plus
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.